Tech Company Financing Transactions

Homology Medicines Funding Round

5AM Ventures, Arch Venture Partners and Deerfield Capital participated in a $43.5 million Series A capital raise for Homology Medicines. This venture round was announced on 5/3/2016.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

45 Wiggins Ave.
Bedford, MA 01730
USA

Phone

Undisclosed

Website

www.homologymedicines.com

Email Address

[email protected]

Overview

Homology is a genetic medicines company translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Arthur Tzianabos

        

Chief Financial Officer

Brad Smith

        

Chief Operating Officer

Sam Rasty

        

Chief Scientific Officer

Albert Seymour

        

Chief Technical Officer

Timothy Kelly

        

Vice President

Theresa McNeely

        

Browse more venture capital transactions:

Prev: 5/3/2016: CarVi venture capital transaction
Next: 5/3/2016: Sqreen venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary